15 completed. 10 Phase 1, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 10 | Completed 10 |
| Phase 2 | 5 | Completed 5 |
Follow this drug Literature Review of AZD1981 trials Research Report on AZD1981
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Chemoattractant Receptor-homologous Molecule Expressed on T Helper Type 2 (CRTh2) Antagonist AZD1981 in Chronic Idiopathic Urticaria (CIU) Antihistamines AZD1981, Placebo - Chronic Idiopathic Urticaria | Phase 2 | Completed | Johns Hopkins University | 38 | 2014-01-01 | 2017-07-12 |
| A Bioavailability Study Comparing 3 Different AZD1981 Tablets AZD1981, current small-particle tablet, AZD1981, new small-particle tablet, AZD1981, new large-particle table - Healthy | Phase 1 | Completed | AstraZeneca | 16 | 2011-04-01 | 2011-07-07 |
| A Drug-Drug Interaction Study Between AZD1981 and Pravastatin to Study the Effect of AZD1981 on the Kinetics of Pravastatin AZD1981, pravastatin - Drug Interaction | Phase 1 | Completed | AstraZeneca | 30 | 2011-02-01 | 2011-04-29 |
| To Investigate the Effects of AZD1981 on the QT Interval AZD1981, 2000mg, AZD1981, 200mg, Moxifloxacin, 400mg - Asthma | Phase 1 | Completed | AstraZeneca | 44 | 2011-01-01 | 2011-06-28 |
| A Drug-Drug Interaction Study to Study the Effect of AZD1981 on Warfarin AZD1981, Warfarin - Pharmakokinetic | Phase 1 | Completed | AstraZeneca | 28 | 2010-10-01 | 2011-02-09 |
| Pharmacokinetics in Adolescents AZD1981 100 mg twice daily for 61/2 days - Asthma | Phase 1 | Completed | AstraZeneca | 21 | 2010-10-01 | 2011-03-07 |
| Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients AZD1981, Placebo - Asthma Patients | Phase 2 | Completed | AstraZeneca | 1144 | 2010-10-01 | 2013-11-06 |
| A Drug-drug Interaction Study to Investigate the Effects of AZD1981 on the Metabolism and Pharmacodynamics of Oral Contraceptives AZD1981, Neovletta 21/28, Placebo AZD1981 - Oral Contraceptives | Phase 1 | Completed | AstraZeneca | 28 | 2010-05-01 | 2010-11-18 |
| Study to Assess the Metabolism, Excretion and Pharmacokinetics of [14C]AZD1981 in Healthy Male Volunteers AZD1981 - Healthy | Phase 1 | Completed | AstraZeneca | 4 | 2010-02-01 | 2010-11-18 |
| AZD1981 Bioavailability Study of Intravenous (IV) and Oral Formulations AZD1981 - Healthy, Postmenopausal | Phase 1 | Completed | AstraZeneca | 14 | 2009-06-01 | 2009-07-30 |
| AZD1981 Midazolam CYP4503A Induction Study AZD1981, Midazolam - Healthy Male Volunteer | Phase 1 | Completed | AstraZeneca | 28 | 2009-03-01 | 2009-04-10 |
| 14729-D9831C00002- 1 Month Biopsy Study AZD1981, Placebo - Chronic Obstructive Pulmonary Disease | Phase 2 | Completed | AstraZeneca | 52 | 2008-11-01 | 2014-02-28 |
| One Month Dose Response Study of AZD1981 in Asthma Patients Uncontrolled on Inhaled Steroids AZD1981, Placebo - Asthma | Phase 2 | Completed | AstraZeneca | 368 | 2008-09-01 | 2014-02-26 |
| Single and Multiple Ascending Doses of AZD1981 in Japan AZD1981, Placebo - Healthy | Phase 1 | Completed | AstraZeneca | 47 | 2008-08-01 | 2010-12-01 |
| Study to Assess the Efficacy and Safety of AZD1981 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) AZD1981, Placebo - Moderate to Severe COPD | Phase 2 | Completed | AstraZeneca | 118 | 2008-05-01 | 2014-01-15 |
Asthma (3) · Pulmonary Disease, Chronic Obstructive (2) · Chronic Urticaria (1)
AstraZeneca (14) · Johns Hopkins University (1)
Sweden (8) · United Kingdom (3) · Argentina (2) · Brazil (2) · Poland (2) · Slovakia (2) · United States (2) · Bulgaria (1) · Costa Rica (1) · Denmark (1) · Germany (1) · Japan (1) · Mexico (1) · Netherlands (1) · Romania (1)
Aslak Rautio (3) · Eva Pettersson (2) · Eva S Pettersson (2) · Chris O'Brien, MD (1) · Christer Hultquist (1) · Christer Hultqvist, MD (1) · Elisabeth Eden (1) · Elizabeth Hancox (1) · Norbert Krug (1) · Piotr Kuna (1) · Sarbjit S Saini, MD (1) · Tim Mant, Professor (1)